Genetic and proteomic features associated with survival after treatment with erlotinib in first-line therapy of non-small cell lung cancer in Eastern Cooperative Oncology Group 3503.

Source:http://linkedlifedata.com/resource/pubmed/id/20035238

Download in:

View as

General Info

PMID
20035238